Mean length of stay and prognosis in unstable angina. Results from the ARIAM database;Estancia media y pronóstico en la angina inestable. Resultados del registro ARIAM

Medicina Clinica

Volumn 128, Issue 8, 2007, Pages 281-290

  Ruiz Bailén, Manuel ^a,f   Macías Guarasa, Inés ^b   Rucabado Aguilar, Luis ^a   Torres Ruiz, Juan Miguel ^b   Castillo Rivera, Ana María ^a   Mármol, Antonio Pintor ^c   Ruiz, Manuela Expósito ^c   Benitez Parejo, José ^d   Rodríguez García, Juan José ^d   Ramos Cuadra, José Ángel ^d   García Alcántara, Ángel ^d   Macías Guarasa, Javier ^e  

^a Unidad de Medicina Intensiva   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c Hospital Universitario Medico Quirurgico   (Spain)

^d UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^e NONE

^f NONE   (Spain)

Author keywords

Length of stay; Mortality; Percutaneous coronary intervention; Unstable angina

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL VENTILATION; ATRIOVENTRICULAR BLOCK; CARDIOGENIC SHOCK; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE FAILURE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SPAIN; UNSTABLE ANGINA PECTORIS;

EID: 34147220953     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13099578     Document Type: Article

References (47)

1. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. American College of Cardiology; American Heart Association. Committee on the Management of Patients With Unstable Angina. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40:1366-74.
2. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;248:835-42.
3. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy) - Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-87.
4. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med. 1998 339;7:443-1887.
5. Fragmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 1999;28;354:708-15.
6. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet. 2000;356:9-16.
7. Bassand JP. Improving the quality and dissemination of guidelines: the quest for the Holy Grail. Eur Heart J. 2000;21:1289-90.
8. Álvarez Bueno M, Vera Almazán A, Rodríguez García JJ, Ferriz Martín JA, García Paredes T, García Alcántara A, et al. Concepto, desarrollo y objetivos del proyecto ARIAM. Med Intensiva. 1999;23:273-80.
9. Aguayo de Hoyos E, Reina Toral A, Colmenero Ruiz M, Barranco Ruiz M, Pola Gallego de Guzmán MD, Jiménez Quintana MM, et al. [Analysis of delays in the treatment of acute coronary syndrome. Data in the Registry ARIAM]. Med Intensiva. 1999;23:280-7.
10. Reina Toral A, Aguayo de Hoyos E, Colmenero Ruiz M, Camacho Víctor A, Medina García P, Fernández Sacristán MA, et al. Mortalidad en el infarto agudo de miocardio. Med Intensiva. 1999;23:288-93.
11. González Díaz F, Guerrero Gómez FJ, Martínez Coronel JF, Vicente Rull J, Martín Rubí JC, Ortiz del Pino AM, et al. Agentes fibrinolíticos en el proyecto ARIAM. Razones de exclusión y complicaciones. Med Intensiva. 1999;23:294-300.
12. Saturno PJ, Felices F, Segura J, Vera A, Rodríguez JJ, ARIAM Group. Reducing time delay in the thrombolysis of myocardial infarction: An internal quality improvement project. Am J Med Quality. 2000,15:85-93.
13. Aguayo de Hoyos E, Reina Toral A, Ruiz Bailén M, Colmenero Ruiz M, García Delgado M. Cuidados prehospitalarios del síndrome coronario agudo. Experiencia del grupo ARIAM. Aten Primaria. 2001;27:478-83.
14. Azpitarte Almagro J, Cabadés A, O'Callaghan A, López Merino V, De los Reyes López M, San José Garagarza JM. Angina de pecho. Concepto y clasificación. Rev Esp Cardiol. 1995;48:373-82.
15. Ruiz Bailén M, Aguayo de Hoyos E, Ramos-Cuadra JA, Díaz-Castellanos MA, Issa-Khozouz Z, Reina-Toral A, et al. Influence of age of management and clinical evolution of patients with acute myocardial infarction of Spanish population. Int J Cardiol. 2002;85:285-96.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med. 1985;13:818-29.
17. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol. 1967;20:457-64.
18. Cabadés A, Echanove I, Cebrián J, Cardona J, Valls F, Parra V, et al. Características, manejo y pronóstico del paciente con infarto agudo de miocardio en la Comunidad Valenciana en 1995; resultados del registro PRIMVAC (Proyecto de Registro de Infarto Agudo de Miocardio de Valencia, Alicante y Castellón). Rev Esp Cardiol. 1999;52:123-33.
19. De Velasco JA, Cosín J, López-Sendón JL, De Teresa E, De Oya M, Sellers G, et al. Nuevos datos sobre la prevención secundaria del infarto de miocardio en España. Resultados del estudio PREVESE II. Rev Esp Cardiol. 2002;55:801-9.
20. Boch X, López de Sá E, López Sendón J, Aboal J, Miranda-Guardiola F, Bethencourt A, et al. Perfil clínico, pronóstico y variabilidad en el tratamiento del síndrome coronario agudo sin elevación del segmento ST. Datos del registro PEPA. Rev Esp Cardiol. 2003;56:346-53.
21. Scirica BM, Moliterno D, Every NR, Aquirre FV, Granger CB, Lambrew CT, et al. Differences between men and women in the management of unstable angina pectoris. (The GUARANTEE registry). Am J Cardiol. 1999;84:1145-50.
22. Kim C, Schaaf CH, Maynard C, Every N. Unstable angina in the Myocardial Infarction Triage and Interventon Registry (MITI): short and long term outcomes in men and women. Am Heart J. 2001;141:73-7.
23. Lacroix AZ, Guraalnik JM, Curb DJ, Wallace RB, Ostfeld AM, Hennedens CH. Chest pain and coronary heart disease mortality among older men and women in three communities. Circulation. 1990;81:437-46.
24. Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O'Leary D, et al. Prevalence of subclinical atheoesclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 1994;139:1164-79.
25. Harris Rb, Weissfeld LA. Gender differences in the reliability of reporting symtoms of angina pectoris. J Clin Epidemiol. 1991;44:1071-8.
26. Garber CE, Carleton RA, Seller GV. Comparison of Rose questionnaire angina to exercise thallium scintigraphy: diferent findings in males and females. J Clin Epidemiol. 1992;45:715-20.
27. Lerner DJ, Kannel WB. Pattern of coronary heart disease morbidity and mortality in the sexes: a 26 year follow-up of the Framingham population. Am Heart. 1986;111:383-90.
28. Scirica BM, Moliterno DJ, Every NR, Anderson HV, Aguirre FV, Granger CB, et al. Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry. Am Heart J. 1999;138:1065-72.
29. Hasdai D, Behar S, Vallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002;23:1190-201.
30. Deepak LB, Matthew TR, Peterson E, Li Y, Chen AI, Harrington RA, et al; for the CRUSADE Investigators. Utilization of Early Invasive Management Strategies for High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative. JAMA. 2004;292:2096-104.
31. Théroux P, Alexander J, Pharand C, Barr E, Snapinn S, Ghannam AF, et al. Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction. Results from the platelet receptor inhibition in ischemic syndrome managemente in patients limited by unstable signs and symptoms (PRISM-PLUS) study. Circulation. 2000;102:2466-72.
32. Kaul P, Fu Y, Chang WC, Harrington RA, Wagner GS, Goodman SC, et al. Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonist for the Reduction of Acute Global Organization Network. J Am Coll Cardiol. 2001;38:64-71.
33. Mujerjee D, Mahaffey KW, Moliterno DJ, Harrington RA, Yadav JS, Pieper KS, et al. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary syndrome events in a Global Organization Network B (PARAGON B). Am Heart J. 2002;144:995-1002.
34. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordón F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003;56:253-61.
35. Steg PG, Dabbo OH, Feldman LJ, Cohen Solal A, Aumont MC, López Sendón J, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation. 2004;106:440-2.
36. Fox KAA. An Introduction to the Global Registry of Acute Coronary Events: GRACE. Eur Heart J. 2000;2:21-34.
37. Philippe F, Larrazet F, Dibie A, Bouabdallah K, Carbognani D, Folliguet T, et al. Management of acute coronary syndromes in a new French coronary intensive care unit. The first four years of activity in the GRACE registry (Global Registry of Acute Coronary Events). Ann Cardiol Angeiol (Paris). 2005;54:68-73.
38. Cho L, Bhatt DL, Marso SP, Brennan D, Holmes DR Jr, Callif RM, et al. An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial. Am J Med. 2003;114:106-11.
39. Jhot UN, Jia G, Moliterno DJ, Lincoff AM, Knot MB, Harrington RA, et al. Prognostic importance of physical examination for heart failure in non-ST elevation acute coronary syndromes: the enduring value of killip classification. JAMA. 2003;290:2174-81.
40. Hasdai D, Harrington RA, Hochman JS, Califf RM, Battler A, Box JW, et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol. 2000;36:685-92.
41. Ruiz-Bailén M, Aguayo De Hoyos E, Issa-Khozouz Z, Díaz-Castellanos M, López-Martínez A, Calatrava- López J, et al. Clinical implications of acute myocardial infarction complicated by high grade atrioventricular block. Med Sci Monit. 2002;8:CR138-47.
42. Ruiz Bailén M. Reversible myocardial dysfunction in critically ill, non-cardiac patients. Critical Care Med. 2002;30:1280-90.
43. Chandra KK, Malhotra S, Gupta M, Graver A, Sharma N, Pandhi P. Changing trends in the hospital management of unstable angina: a drug utilization analysis. Int J Clin Pharmacol Ther. 2004;42:575-80.
44. Stewart SBA, Grad D, Voss D. A study of un planned readmissions to a coronary care study. J Am Cardiol. 1997;26:196-203.
45. Almeda FQ, Hendel RC, Nathan S, Meyer PM, Calvin JE, Klein LW. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores. J Invasive Cardiol. 2003;15:502-6.
46. Bordi V, Sanchis J, Llácer A, Fácila L, Pellicer M, Bertomeu V, et al. Diferencias entre sexos en la mortalidad a un mes y a un año tras un síndrome coronario agudo. Med Clin (Barc). 2004;112:566-9.
47. Sendrá JM, Sarría-Santamera A, Íñigo J, Regidor E. Factores asociados a la mortalidad intrahospitalaria del infarto de miocardio. Resultados de un estudio observational. Med Clin (Barc). 2005;125:641-6.